NZ216306A
(en )
1989-10-27
Pharmaceutical compositions containing tissue plasminogen activator
AU6806487A
(en )
1987-07-30
Tissue plasminogen activator
NZ216307A
(en )
1989-10-27
Pharmaceutical compositions containing tissue plasminogen activator
DK96787D0
(en )
1987-02-25
HUMAN VAEVS PLASMINOGEN ACTIVATOR
NZ217331A
(en )
1989-05-29
Tissue plasminogen activator derivatives and genetically engineered product
HU912739D0
(en )
1992-01-28
Stabilization of glycozylized tissue plasminogene activator (t-pa)
AU3838189A
(en )
1990-01-12
Tissue plasminogen activator analogues having improved activity
AU589283B2
(en )
1989-10-05
Synergistic blood clot treatment composition comprising tissue plasminogen activator and a prostaglandin
IL91774A0
(en )
1990-06-10
Preparation of plasminogen activator expressed in prokaryotes
IE882534L
(en )
1989-02-21
Peg complex of tissue plasminogen activator
GB2247031B
(en )
1993-10-27
Reinforcement of tissue
ZA863956B
(en )
1988-04-27
Pharmaceutical formulations containing tissue plasminogen activator
GB8815245D0
(en )
1988-08-03
New tissue plasminogen activator
GB8901422D0
(en )
1989-03-15
New tissue plasminogen activator
ZA884012B
(en )
1989-02-22
Tissue plasminogen activator analogs having modified growth factor domains
EP0417298A4
(en )
1993-03-10
Detection of human tissue factor activator
GB8826692D0
(en )
1988-12-21
Tissue plasminogen activator
AU7090787A
(en )
1987-10-08
Tissue plasminogen activator
IL78450A0
(en )
1986-08-31
Agent containing tissue plasminogen activator(t-pa)
GB8815247D0
(en )
1988-08-03
New tissue plasminogen activator
GB8815246D0
(en )
1988-08-03
New tissue plasminogen activator
IE870208L
(en )
1987-07-29
Modified tissue plasminogen activator
GB8726683D0
(en )
1987-12-16
Tissue plasminogen activator
GB8725052D0
(en )
1987-12-02
Tissue plasminogen activator
GB8718298D0
(en )
1987-09-09
Tissue plasminogen activator